Overview
Justin Simmons is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. He has been practicing medicine for over 17 years.
His clinical expertise encompasses Pseudomyxoma Peritonei, Febrile Neutropenia, Metastatic Brain Tumor, Endoscopy, and Bone Marrow Aspiration.
Dr. Simmons is board certified in Hematology, Internal Medicine, and Medical Oncology. He is actively involved in clinical research, co-authoring 2 peer reviewed articles. Dr. Simmons is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
75 Francis St, Boston, MA 02115
Additional Areas of Focus
Dr. Simmons has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Dana-Farber Cancer Institute, Center For Neuro-Oncology
David Reardon is a Hematologist Oncology specialist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Reardon is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Reardon is currently accepting new patients.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Dana-Farber Cancer Institute, Breast Oncology Program
Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School. She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer. She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials. Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology. Dr. Tolaney is currently accepting new patients.
Dana-Farber Cancer Institute
Eric Jacobsen is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Jacobsen is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Reticulohistiocytoma, and Bone Marrow Aspiration. Dr. Jacobsen is currently accepting new patients.
Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center
Paul Richardson is a Hematologist Oncology specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Richardson is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Hepatic Venoocclusive Disease with Immunodeficiency, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Graft. Dr. Richardson is board certified in Medical Oncology. Dr. Richardson is currently accepting new patients.
Frequently Asked Questions about Dr. Justin L. Simmons
Is Dr. Justin L. Simmons a top-rated expert for Pseudomyxoma Peritonei?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Justin L. Simmons is classified as an Experienced expert for Pseudomyxoma Peritonei, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Justin L. Simmons specialize in?
While Dr. Justin L. Simmons is a Hematology, they have specific expertise in Pseudomyxoma Peritonei, Febrile Neutropenia, and Endoscopy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Justin L. Simmons participate in research or clinical trials?
Yes. Dr. Justin L. Simmons has published 2 articles and abstracts on conditions like Pseudomyxoma Peritonei. You can view a list of Dr. Justin L. Simmons's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Justin L. Simmons accept my insurance?
Dr. Justin L. Simmons accepts most major insurance plans, including Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AgranulocytosisDr. Simmons isExperienced. Learn about Agranulocytosis.
- Bone Marrow AspirationDr. Simmons isExperienced. Learn about Bone Marrow Aspiration.
- Chronic Familial NeutropeniaDr. Simmons isExperienced. Learn about Chronic Familial Neutropenia.
- EndoscopyDr. Simmons isExperienced. Learn about Endoscopy.
- Febrile NeutropeniaDr. Simmons isExperienced. Learn about Febrile Neutropenia.
- Metastatic Brain TumorDr. Simmons isExperienced. Learn about Metastatic Brain Tumor.
- Posterior Fossa TumorDr. Simmons isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Simmons isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Pseudomyxoma PeritoneiDr. Simmons isExperienced. Learn about Pseudomyxoma Peritonei.
- Stomach CancerDr. Simmons isExperienced. Learn about Stomach Cancer.

